|1.||Wang, Xin: 1 article (01/2010)|
|2.||Yi, Pengfei: 1 article (01/2010)|
|3.||Wei, Xubin: 1 article (01/2010)|
|4.||Guo, Yang: 1 article (01/2010)|
|5.||Mu, Xiang: 1 article (01/2010)|
|6.||Duchateau, L: 1 article (07/2002)|
|7.||Cox, E: 1 article (07/2002)|
|8.||Deprez, P: 1 article (07/2002)|
|9.||Verdonck, F: 1 article (07/2002)|
|10.||Van der Stede, Y: 1 article (07/2002)|
01/01/2010 - "Analysis of the data suggested that CTCM specifically and effectively reduced microvascular endothelial cell permeability to SLT-IIv in the treatment of pig edema disease. "
01/01/1995 - "By contrast, only in 1 of 28 (3.57%) serum samples of pigs with edema disease caused by SLT-IIv-producing E. "
04/01/1993 - "The role of adhesive F107 fimbriae and of SLT-IIv toxin in the pathogenesis of edema disease in pigs."
03/01/1992 - "In multiple experiments, 3-week-old pigs were weaned, then inoculated intragastrically with 10(10) colony-forming units of an SLT-IIv-positive strain of Escherichia coli originally isolated from a pig with edema disease (principals). "
07/01/1989 - "coli TB1 (pCG5) and E145 contained high levels of Shiga-like toxin IIv and induced signs and lesions similar to those seen in edema disease, whereas preparations from E. "
07/26/2002 - "Therefore, the fimbriae-specific antibody response of newly weaned pigs following infection with the Shiga-like toxin type II variant (SLT-IIv) producing F18(+) verotoxigenic E. "
01/01/1995 - "Since all animals seroconverted in the follow-up sera, the antigenicity of SLT-IIv during infection of pigs seems to differ from that of SLT-II in human hemolytic uremic syndrome where only a minority of patients are known to mount an immune response. "
02/01/1992 - "Edema disease (ED) of weanling pigs is caused by an infection with Escherichia coli that produces Shiga-like toxin II variant (SLT-IIv). "
05/01/1994 - "Colony blot ELISA with the SLT-II specific MAb11E10 detected 27 of 28 strains with slt-II sequences, but did not react with any of the seven strains that carried slt-IIv, or slt-I and slt-IIv. The high SLT variability shown here has diagnostic implications and may well have consequences for the host response in infections associated with these pathogens."
|3.||Body Weight (Weight, Body)
02/01/1992 - "Pathology identical to that caused by ED can be duplicated in pigs that are injected with less than 10 ng of purified SLT-IIv per kg of body weight. "
01/01/1991 - "4, 5, 6) of six pigs each were injected with 6, 3, and 1.5 ng, respectively, of SLT-IIv/kg of body weight. "
01/01/1991 - "1, 2, 3) were injected with 48, 24, and 12 ng, respectively, of SLT-IIv/kg of body weight. "
|1.||Shiga Toxin 2
|2.||Shiga Toxin 1 (SLT-I)
|3.||Shiga-Like Toxin IIv
|4.||Shiga Toxins (Vero Toxin)
|6.||Immunoglobulin M (IgM)
|7.||Immunoglobulin G (IgG)
|8.||DNA (Deoxyribonucleic Acid)